| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/20/2004 | US6764675 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 07/20/2004 | CA2196610C Flow through electroporation apparatus and method |
| 07/15/2004 | WO2004058965A1 Method of separating precursor cells producing gabaergic nerve cells alone |
| 07/15/2004 | WO2004058952A1 Method of culturing autologous cell using injectable solid powder |
| 07/15/2004 | WO2004058323A2 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 07/15/2004 | WO2004058305A2 Encapsulated cell for therapy |
| 07/15/2004 | WO2004057981A1 Lactic-acid fermented materials able to restrain rotavirus infection and thereof producting method |
| 07/15/2004 | WO2004057961A1 Method of prolonging the life-span of living cells using nadh, nadph and adp-ribose |
| 07/15/2004 | WO2004046346A3 Self-containing lactobacillus strain |
| 07/15/2004 | WO2004044149A3 Method for suppressing immune system response to transplanted tissue or cells |
| 07/15/2004 | WO2003093431A3 Ablated slam-dependent entry |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003078586A3 Vascularized tissue for transplantation |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 07/15/2004 | US20040138329 Gels for encapsulation of biological materials |
| 07/15/2004 | US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor |
| 07/15/2004 | US20040138167 Administering a nucleic acid; prevention infections, Dna damage, tumors,skin disorders |
| 07/15/2004 | US20040138134 Method and composition for treatment of skeletal dysplasias |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040138103 Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto |
| 07/15/2004 | US20040137617 Purification of antigen-specific T cells |
| 07/15/2004 | US20040137616 Corneal epithelial graft composites |
| 07/15/2004 | US20040137614 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 07/15/2004 | US20040137612 Bone marrow multipotent stem cells for propagation of osteoblast, chrondrocytes, myoblasts, adipocytes, endothelial and neuronal tissues; tissue engineering |
| 07/15/2004 | US20040137419 Contacting blood product with a cation exchange resin, allow for binding and separating the positively charged aziridino compound; Dowex 50wx8; ethyleneimine oligomers |
| 07/15/2004 | US20040137085 Treatment of HIV infection with humic acid |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137073 Establishes a dose dependant correlation between the amount of bovine colostrum consumed as a food supplement and the levels of increase of immunoglobulins and lymphocytes present in the immune system |
| 07/15/2004 | US20040137072 Reducing the risk of osteoporosis and other bone-loss disorders in females; increases the bioavailability of metabolites involved in bone mineral loss and calcium absorption control |
| 07/15/2004 | US20040137042 Multi-formed collagenous biomaterial medical device |
| 07/15/2004 | US20040136978 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 07/15/2004 | US20040136972 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 07/15/2004 | US20040136971 Implantation of encapsulated biological materials for treating diseases |
| 07/15/2004 | US20040136969 cellular composition consisting of greater than 20% adult bone marrow derived cells, depleted of hematopoietic cells and matured leucocytes; having phenotype of CD45-, Lin- and Sca+ |
| 07/15/2004 | US20040136968 Autologous cells on a support matrix for tissue repair |
| 07/15/2004 | US20040136967 Cultures, products and methods using stem cells |
| 07/15/2004 | US20040136966 implantation of hematopoietic stem cells into the myocardium surrounding an infarct following a myocardial infarction, migrate into the damaged area, where they differentiate into myocytes, endothelial cells and smooth muscle cells |
| 07/15/2004 | US20040134502 Method for in situ repair of injured, damaged, diseased or aged articular cartilage |
| 07/15/2004 | CA2510503A1 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 07/14/2004 | EP1437406A2 Pluripotent stem cells originating in skeletal muscle intestinal tissue |
| 07/14/2004 | EP1437404A1 Tailor-made multifunctional stem cells and utilization thereof |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437365A1 Use of cardiotrophin in hepatic diseases |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436413A2 Response of dendritic cells to a diverse set of pathogens |
| 07/14/2004 | EP1436403A2 Use of the adenoviral e2 late promoter |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436392A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436387A2 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n-acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436380A2 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 07/14/2004 | EP1436015A2 Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| 07/14/2004 | EP1436013A2 Method for inducing growth and enhancing survival of nervous tissue |
| 07/14/2004 | EP1436005A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 07/14/2004 | EP1435980A1 Stratified cartilage tissue and methods to engineer same |
| 07/14/2004 | EP1435977A1 Cardiac transplantation of stem cells for the treatment of heart failure |
| 07/14/2004 | EP1435907A2 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 07/14/2004 | EP1435906A2 Method for producing biologically active products |
| 07/14/2004 | EP1435788A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 07/14/2004 | EP1435787A2 Nestin-expressing hair follicle stem cells |
| 07/14/2004 | EP1435779A2 Modulation of stem cells using zinc finger proteins |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1337625B1 Stem cells, method for expansion in vitro and use thereof |
| 07/14/2004 | EP0825868B1 Prevention or treatment of alimentary tract damage due to chemotherapy or radiation |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0814819B1 Sertoli cells as transplantation facilitator for cell transplantation |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | CN1513056A Production of bioarailable folic acid |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512892A Orally administering parathyroid hormone and calcitonin |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511945A Lactic bacillus strain and its separating and breeding method and use |
| 07/14/2004 | CN1511938A Health care wine |
| 07/14/2004 | CN1157407C Human interleukin-6 inhibitor |
| 07/14/2004 | CN1157228C Method for the production of tablets by pressing and tablets produced by the method |
| 07/14/2004 | CN1157219C 治疗癌症的药物 Cancer drugs |
| 07/14/2004 | CN1157218C Medicine for curing rheumatism and rheumatoid arthritis |
| 07/14/2004 | CN1157216C Toxic substance removing ointment and its preparing method |
| 07/14/2004 | CN1157215C Chinese medicine composition for curing cancers |
| 07/14/2004 | CN1157214C Pure Chinese medicine prepn for treating psychosis |
| 07/14/2004 | CN1157213C Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma |
| 07/14/2004 | CN1157207C Chinese medicine with physique enhancing and disease treating functions and its producing process |
| 07/14/2004 | CN1157205C Ointment for treating ostalgia |
| 07/14/2004 | CN1157204C Mother liquid medicine for treating liver cancer and its preparing process |
| 07/14/2004 | CN1157201C Composite non-opium medicine for dropping drugs |
| 07/14/2004 | CN1157198C Bolus for bone setting and activating collaterals |
| 07/14/2004 | CN1157197C Pharmaceutical for treating injury type vetebral injure |
| 07/14/2004 | CN1157195C Soft capsule of superfine compound pearl powder and its preparing process |
| 07/14/2004 | CN1157194C Method for processing freeze-dried deer blood |
| 07/14/2004 | CN1157189C Semi-synthetic ecteinascidins |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6761898 Carnitine or alkanoyl-l-carnitine and glucosaminoglycan |
| 07/13/2004 | US6761885 Used for treating and/or preventing urogenital infections |
| 07/08/2004 | WO2004056397A1 Stimulation of hematopoiesis by ex vivo actived immune cells |
| 07/08/2004 | WO2004056378A1 Means for preventing and curing endocrine system disturbances |
| 07/08/2004 | WO2004056377A1 Orthochromatic rare earth elements screen film system for intra-oral odontological radiology |